parenteral dosage

parenteral dosage

pertaining to a medication administered by a route that bypasses the GI tract, such as a drug given by injection.
References in periodicals archive ?
Lonza announced today that its Pharma & Biotech segment is expanding its footprint for Parenteral Dosage Form development with a further build-out of its Drug Product Services (DPS).
An rphplc method for simultaneous estimation of Ceftriaxone sodium and sulbactam sodium in parenteral dosage form," International Journal of Pharmacy and Pharmaceutical Sciences, vol.
Implantable drug delivery devices offer several advantages over conventional oral or parenteral dosage forms.
First, two different GMP zone-concepts within the controlled production areas for solid oral dosage forms and for parenteral dosage forms were designated.
Upon completion of the deal, Evonik will have control of SurModics' parenteral dosage technology platforms and services and bioresorbable lactide-glycolide polymers business.
Purpose: Due to multiple court cases regarding the labelling of anthroposophic preparations in parenteral dosage forms containing mistletoe the Federal Institute For Drugs and Medical Devices (BfArM) invited the anthroposophic Marketing Authorization Holders (MAHTs) to discuss a compromise resulting in a revision of the standard Summary of Product Characteristic (SPC) for all relevant preparations.
Formulating these compounds as pure drug nanoparticles has been shown to improve bioavailability and enhance drug exposure for oral and parenteral dosage forms.
Excipients for oral solid dosage (tabletting), oral liquid dosage and parenteral dosage forms
Polymer and chemical compounds adapted to protein- and peptide-based pharmaceuticals offer the best long-term growth prospects among all oral drug delivery systems due to ease-of-administration and cost benefits over parenteral dosage formats.
This grants Evonik ownership of SurModics' parenteral dosage technology platforms and services and bioresorbable lactide-glycolide polymers business.
The main challenge of all the different parenteral dosage forms is to achieve a good compatibility of the drug substances with the excipients--no formation of new impurities either by degradation of the drug substance or formation of new chemical entity between the drug substance and the excipients--as well as the compatibility of the preparations with the primary container--no leachable or adsorption to container.
Representatives of the companies AbbVie, Eli Lilly, NNE Pharmaplan, Roche Diagnostics and Vetter Pharma reported on unusual projects, current challenges and future trends, such as filling of highly potent pharmaceuticals and innovative approaches for the development of parenteral dosage forms.